Tus kws kho mob
QP37-26 Commercial Pharmacy Benefit Exclusion for Epioxa™ HD/Epioxa, Fensolvi®, Fesilty™, Midazolam, Photrexa®, Wainua®, Zemaira®, and Zoladex®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 27, 2026
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 4271 - 4274 ntawm 4274
Tus kws kho mob
QP36-26 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 27, 2026
Tus kws kho mob
QP35-26 Intensive Residential Treatment Services (IRTS) Prior Authorization (PA) Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 27, 2026
Tus kws kho mob
QP34-26 Billing Changes for Opioid Treatment Programs for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 27, 2026